Navigation Links
Lightlake Therapeutics to Present at 6th Annual LD MICRO Conference
Date:11/20/2013

LONDON, Nov. 20, 2013 /PRNewswire/ -- Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it is scheduled to present at LD MICRO's 6th Annual Conference on Wednesday, December 4th, 2013, at 8:30 AM PST / 11:30 AM EST. The three-day event will host more than 200 companies in the micro-cap space at the Luxe Sunset Boulevard Hotel in Los Angeles, California.

Dr. Roger Crystal, CEO of Lightlake, will be presenting to investors and be available for one-on-one meetings during the conference.

About Lightlake Therapeutics

Lightlake Therapeutics Inc., a London-based biopharmaceutical company, is using its expertise in opioid antagonists to build a platform of innovative solutions to common addictions and related disorders. The Company holds patents covering the use of intranasal naloxone to treat Binge Eating Disorder ("BED") as well as patents covering addiction to drugs including cocaine, amphetamine, and MDMA. Lightlake is currently focused on advancing its treatment for BED, which has successfully completed Phase II clinical trials, and a Phase II trial is planned for the indication of Bulimia Nervosa. Lightlake is also applying its technology to develop a treatment for managing the complications of opioid drug addiction in collaboration with the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. For more information please visit: http://www.lightlaketherapeutics.com

About LD MICRO

LD MICRO is a by-invitation-only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks, as well as comprehensiv
'/>"/>

SOURCE Lightlake Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lightlake Therapeutics Retains KCSA Strategic Communications as Corporate Communications Advisors
2. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
3. Northwest Biotherapeutics Announces Proposed Public Offering Of Common Stock [and Warrants]
4. Prostate Cancer Therapeutics Market Worth $8.0 billion by 2019
5. Edison expands international bio-pharmaceutical presence with launch of coverage of Onconova Therapeutics
6. Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership
7. Signum Dermalogix Receives $1.6M Phase II SBIR Grant for the Development of Novel Atopic Dermatitis Therapeutics
8. PTC Therapeutics Reports Third Quarter 2013 Financial and Corporate Results
9. Aratana Therapeutics Reports Third Quarter 2013 Financial Results
10. Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws
11. Argos Therapeutics to Present at the Elsevier Therapeutic Area Partnerships Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global ... participating in the Morgan Stanley 2014 Global Healthcare Conference ... New York , on Tuesday, September 9, 2014.  ... will be presenting at 9:10 a.m. Eastern Time.  ... join Mr. Dvorak for the Q&A session. ...
(Date:8/27/2014)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading ... announced the results of the Company,s 2014 Annual General Meeting of ... , PRC. The required quorum, a majority of the common ... shareholders approved the following proposals:  , The re-election of ... Anderson , Kenneth Lee and Meng Mei ...
(Date:8/27/2014)...  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), ... commercialization of innovative therapies for the treatment of acute ... be participating at the FBR Healthcare One on One ... Conference.  Details of the two events are as follows: ... Wednesday September 3 rd Location: Four Seasons, ...
Breaking Medicine Technology:Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 3
... April 18, 2011 Qmed.com, a UBM Canon ... informative video clips of products and services available ... Vault . Qmed is a free online search ... access to pre-qualified medical device suppliers. ...
... 18, 2011 Nektar Therapeutics (Nasdaq: NKTR ) ... March 31, 2011 on Wednesday, April 27, 2011, after the ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ...
Cached Medicine Technology:Qmed Video Vault Showcases Innovative New Products and Services Available to Medical Device Manufacturers 2Nektar to Announce Financial Results for the First Quarter of 2011 on Wednesday, April 27, 2011, After Close of U.S.-Based Financial Markets 2
(Date:8/27/2014)... August 27, 2014 IQ Formulations ... today announced its continued support of the Cystic Fibrosis ... participated in a fundraising campaign led by TigerFitness.com in ... IQ Formulations’ sales were donated to the respected nonprofit ... a TigerFitness.com fundraiser to support Isla, a young girl ...
(Date:8/27/2014)... Aspirus Wausau Hospital today announced the first extensive ... O.R. at Aspirus Wausau Hospital, in Wausau, WI. ... will be Buzz, a centralized surgical hub for operating ... navigation, imaging and communications connectivity. , Buzz Digital ... hardware all controlled from the full HD 42” multi-touch ...
(Date:8/27/2014)... 27, 2014 SCOTT Sports is ... Utah’s first indoor mountain bike and BMX park. SCOTT ... bikes in both adult and youth sizes for the park’s ... a distribution warehouse in Ogden, Utah, recently moved its U.S. ... “We are proud to be a partner with the Wasatch ...
(Date:8/27/2014)... By Steven Reinberg ... -- A hormone used to reduce the need for blood ... new study suggests. Synthetic erythropoietin (EPO), which stimulates red ... shortly after preterm birth, said lead researcher Dr. Petra Huppi, ... of Geneva, in Switzerland. "The real test of whether ...
(Date:8/27/2014)... CIC microGUNE, the Co-operative Research Centre into ... seeks to generate innovative solutions based on ... mobility industry and life sciences, among others. ... Tecnun are collaborating with CIC microGUNE on ... funded by the Etortek 2013-2014 programme of ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Contributes Sizeable Donation to Cystic Fibrosis Foundation 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3Health News:Microtechnologies for driving forward mobility and human health 2
... hearing damage from acoustic shock, say health experts. // , ... functioning of the ear or of the nervous system, which ... earphone by a sudden sharp rise in the acoustic pressure ... a bleep or any unexpected noise. Two thirds of call ...
... For patients on hemodialysis, the use of dialysis filters ... approach to the common problem of anemia, reports a ... 39th Annual Meeting and Scientific Exposition in San Diego. ... Hospital in Vicenza, Italy, analyzed the outcomes of 172 ...
... acquired respiratory syndrome (SARS), has been responsible for around ... Researchers from Brookhaven’s biology department and the National Synchrotron ... controlling the virus . They have successfully identified a ... new anti-SARS virus drugs.The stage has been set now ...
... bypass surgery for morbid obesity have increased risk factors ... paper being presented at the American Society of Nephrology's ... ,'Gastric bypass surgery appears to lead to changes ... the formation of kidney stones,' comments Dr. Rajiv Kumar ...
... of clear information about the risks of nanotechnology in ... this powerful potential according //to 14 top international scientists ... issue of the journal Nature. The paper, 'Safe Handling ... nanotechnology risk that must be met if the technology ...
... China for stem cell treatment died on Thursday night in ... ,Willie Terpstra, a New Zealander, was diagnosed with motor ... months ago to have a foetal cell tansplantation operation in ... of voluntary muscle activity that aids speaking, breathing and swallowing. ...
Cached Medicine News:Health News:Vitamin E-Coated Dialysis Filters Help Fight Anemia in Hemodialysis Patients 2Health News:Scientists Close To Identifying Anti-viral Drug for SARS 2Health News:Scientists Close To Identifying Anti-viral Drug for SARS 3Health News:Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk 2Health News:Fear of Possible Harm Hinder Nanotech Development 2
Inquire...
Inquire...
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo...
Inquire...
Medicine Products: